FindTrial
Sign In

A study of the effects of Vitamin C and Vitamin E supplementation on the rate of wound healing in diabetic foot ulcers - A Randomized Controlled Trial.

Effect of Vitamin C and Vitamin E supplementation on wound healing in diabetic foot ulcers - A Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035385
Enrollment
100
Registered
2021-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: VITAMIN C AND VITAMIN E CAPSULES: Patients will be given Tab VITAMIN C 500mg BD AND VITAMIN E 400IU OD for a period of 2 weeks which is expected to accelerate wound healing in diabetic

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ALL PATIENTS MORE THAN 18 YEARS OF AGE WITH DIABETIC FOOT ULCERS

Exclusion criteria

Exclusion criteria: INCLUDES ALL THE PATIENTS WITH a)Venous disease b)Coagulopathy c)Osteomyelitis d)Charcotâ??s joint e)Ulcers of Wagner Grade IV and V f)Peripheral Vascular Disease g)Coexisting CKD, malignancy, and any hematological disorder.

Design outcomes

Primary

MeasureTime frame
To study the effect of vitamin C and vitamin E supplementation on the rate of ulcer healing in diabetic foot ulcer patients.Timepoint: baseline at the time of start of the study , followed by after 2 weeks of intervention for primary outcome of wound healing and blood parameters.—

Secondary

MeasureTime frame
(a)To determine the effect of vitamin C and vitamin E supplementation on long term glycemic control. (b)To determine the effect of vitamin C and vitamin E supplementation on metabolic parameters. Timepoint: hba1c AND blood parameters will also be assessed at the start of the study followed by repeat of the blood parameters at the end of 2 weeks of intervention and hba1c at the end of 4 weeks—

Countries

India

Contacts

Public ContactDrSnehasis Smrutirnjan Das

JIPMER

elamurugantp@gmail.com9443648918

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026